Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 85,711Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3ABBVIE CORPORATION

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2495155

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

02

arrow
2024 ACI Convention
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number : 2520893

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

03

arrow
2024 ACI Convention
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 45MG

Packaging :

Approval Date :

Application Number : 2539721

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner